Clinical studies have confirmed that hyperhomocysteinemia is not only an independent risk factor for the development of cardiovascular and cerebrovascular diseases, such as atherosclerosis, acute myocardial infarction, stroke, coronary artery lesions, and peripheral vascular disease, but also increases the risk of neurodegenerative disorders and tumors, and impairs the efficacy of antifolate drugs
Shike, & A
Son rle dans le mtabolisme lipidique et le soutien nergtique cellulaire en fait une aide valable mme pour ceux qui mnent une vie moins active
This product is not intended for human or veterinary use, diagnostics, or therapeutic purposes
Ph n ti mn kinh, mn kinh mu h n ti v c thi da
Keep reading to learn more, navigate to the FAQ below and visit the Quarterly Drug Pipeline for more clinical insights on anticipated drugs in development